Prevalence of viral hepatitis markers in Korean patients with Hepatocellular Carcinoma

Journal of Korean Medical Science

Volumn 13, Issue 3, 1998, Pages 306-310

  Huh, Kwang ^a   Choi, Soo Yong ^a   Whang, You Sung ^b   Lee, Dong Soon ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Korean Red Cross   (South Korea)

Author keywords

Carcinoma hepatocellular; Hepatitis B surface antigen; Hepatitis C antibodies

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD; CHILD; ENZYMOLOGY; FEMALE; HUMAN; INFANT; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEX DIFFERENCE; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SEX FACTORS;

EID: 0032088304     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1998.13.3.306     Document Type: Article

References (31)

1. Kim JP, Park IS, Ahn YO, Shin MH, Ahn DH, Kang TW, Ko UR, Ku PS, Kim KY, Kim KH, Kim NK, Kim DJ, Kim DH, Kim BS, Kim SH, Park CT, Min JS, Park TK, Woo BH, Yoo H, Lee SW, Lee SJ, Cho KS, Joo HZ, Ham EK. 1991 Cancer incidences in Seoul, Korea: Results of the implementation study of Seoul cancer registry. J Korean Med Sci 1995; 10: 74-84.
2. National Bureau of Statistics. Annual report on the cause of death statistics 1990, Korea, 1991.
3. Kim KH, Lee HR, Min CH, Jeong H, Hong SH, Lee YS, Cha YJ, Yoo BC, Park SM. Prevalence of antibodies to hepatitis C virus in patients with various types of liver diseases. Korean J Intern Med 1992; 7: 9-11.
4. Shin HR, Lee CU, Park HJ, Seol SY, Chung MJ, Choi CH. Risk factors for hepatocellular carcinoma among Koreans - a case-control study in Pusan, Korea. In: Summary Report, Japan-Korea joint study on liver cancer. Fukuoka University, School of Medicine, 1993.
5. Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer 1993; 72: 2564-7.
6. Beasley RP. Hepatitis B virus: the major etiology of hepatocelhilar carcinoma. Cancer 1988; 61: 1942-56.
7. Okuno H, Xie ZC, Lu BY, Qin X, Takasu M, Kano H, Shiozaki Y, Inoue K. A low prevalence of anti-hepatitis C virus antibody in patients with hepatocellular carcinoma in Guangxi province, southern China. Cancer 1994; 73: 58-62.
8. Yu MW, You SL, Chang AS, Lu SN, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991; 51: 5261-5.
9. Lee SD, Lee FY, Wu JC, Hwang SJ, Wang SS, Lo KJ. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992; 69: 342-5.
10. Chung WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ. The role of hepatitis B and C virus in hepatocellular carcinoma in hepatitis B endemic area: a case-control study. Cancer 1992; 69: 2052-4.
11. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873-4.
12. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic system: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 1992; 16: 300-5.
13. Yatsuhashi H, Inoue O, Koga M, Nagayaki S, Mizuno K, Kolberg J, Beall E, Cha TA, Irvine B, Kuo G, Ureda MS, Yano M. Comparison of hepatitis C markers in patients with NANB hepatitis. J virol Methods 1992; 37: 13-22.
14. Jung BC, Lee SH, Kim SI. Prevalence of HBsAg and anti-HCV among Korean blood donors. Korean J Blood Transfusion 1994; 5: 143-50.
15. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978; 24: 40-69.
16. Beasley RP, Hwang LY, Lin CC, Chen CS. Hepatocellular carcinoma and hepatitis B virus; a prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 1229-33.
17. Leung NW, Tam JS, Lai JY, Leung TW, Lau WY, Shiu W, Li AK. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 1992; 70: 40-4.
18. Dazza MC, Meneseses LV, Giard PM, Villaroel C, Brechlot C, Larouze B. Hepatitis C virus antibody and hepatocellualr carcinoma. Lancet 1990; 335: 1216.
19. Milich DR, Jones J, Hughes J, Maruyama T. Hepatitis B virus infection, the immune response and hepatocellular carcinoma, Ciba Found Symp 1994; 187: 113-29.
20. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradly DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 352-62.
21. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
22. Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma, prevalence and significance. Arch Intern Med 1993; 153: 1672-7.
23. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, Yano M, Kuo G, Choo QL, Houghton M, Oda T. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-33.
24. Hamasaki K, Nakala K, Tsutsumi T, Tsuruta S, Nakao K, Kato Y, Shima M, Koji T, Nagataki S. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellualr carcinoma in the Nagasaki Prefecture, Japan. J Med Virol 1993; 40: 146-9.
25. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004-6.
26. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellualr carcinoma. Lancet 1989; 2: 1006-8.
27. Lok AS, Ma OC, Chen TM, Lai CL, Chung HT, Ng CP, Lam JS. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology 1991; 14: 752-62.
28. Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993; suppl: 13-6.
29. Kew MC. The development of hepatocellular cancer in humans. Cancer Surv 1986; 5: 719-39.
30. Kim YS, Pai CH, Chi HS, Kim DW, Min YI, Ahn YO. Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci 1992; 7: 333-6.
31. Tassopoulos NC, Hatzakis A, Delladetsima I, Koutelou MG, Todoulos A, Miriagou V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 1992; 102: 969-72.